https://www.selleckchem.com/pr....oducts/ferrostatin-1
h advanced PDAC into three prognostic groups after progression to the first-line. This score could help in the decision-making for 2L treatment. Postauricular steroid administration has been popular for treating sudden sensorineural hearing loss. However, there are few reports on its use in patients with refractory sudden sensorineural hearing loss (RSSNHL). The objective of this study was to investigate the therapeutic efficacy of postauricular steroid injection as a salvage treatment for RSSNHL patients. This retrospective study
Curtir
Comentario
Compartilhar
